Aldevron

It was a great day at the Advanced Therapies Congress in London yesterday. Tim Traynor had great response to his presentation on mRNA manufacturing with Alchemy™ Cell-free DNA and Codex® HiCap T7 Polymerase, and our crew was happy to meet a lot of people at our display. We look forward to speaking with more of you today at the booth 34 for day 2! #adtherapies25 #advancedtherapies #cellandgenetherapy

Our newest innovation, Alchemy cell-free DNA technology, was featured in Genetic Engineering & Biotechnology News this month! Earlier this year, we launched Alchemy to cut research grade linear DNA manufacturing time by over 50% and accelerate mRNA development projects with cleaner, safer DNA templates. We’re looking forward to continuing to drive innovation in the industry and seeing the impact of this new technology. Check out the article in GEN here: https://ald.bio/4bXNNp3 #InTheNews

It's an exciting week as we kick off Advance Therapies Europe tomorrow in London. Join us at booth 34 to learn about what we can offer for your cell and gene therapy projects, or schedule time with us using this link. We look forward to speaking with you! https://ald.bio/4i31ENb

Destinations can be tricky things, especially considering the obstacles that can pop up during the journey. For therapeutics developers, those obstacles can completely disrupt a development pipeline. But Emily Sether offers up a means to help speed up processes and move around those obstacles. https://ald.bio/3DAU1hW

Cut your research grade linear DNA manufacturing time by over 50% with Next-Gen Alchemy™ Cell-Free DNA Technology! 🧬✨ Alchemy,™ is our revolutionary technology that represents a significant advancement in synthetic DNA manufacturing, offering a cell-free, enzymatic process to generate linear DNA (linDNA) templates for in vitro transcription (IVT) synthesis of mRNA molecules. Accelerate your mRNA development projects with cleaner, safer DNA templates. We're ready to help you move forward with you research-grade applications! https://ald.bio/4h8YTJ4 #Aldevron #Innovation #Biotech #SyntheticDNA #Research #IVT #mRNA #AlchemyTechnology

Streamline Your mRNA-LNP Drug Product Development with Aldevron’s End-to-End Solutions! Efficiency and experience matters when you’re looking for a manufacturing partner for mRNA therapeutics. Aldevron has the proven track record, providing a single-source solution. One manufacturer. One quality system. One ecosystem. Let our expertise be your biggest advantage! Click here to watch the video and to learn more! https://ald.bio/41KgKS9

Ready to propel your CGT therapy forward?  We've just launched Aldevron’s Breakthrough Booster Program. Enjoy exclusive cost savings and access to technical experts to push your cell and gene therapy programs forward in 2025.  Click on the link below to learn more:  https://ald.bio/4kFxGQS

Aldevron's Chief Scientific Officer, Venkata Indurthi is #InTheNews last month with a byline in PharmiWeb! Venkata discusses the future of CRISPR technologies, including advancements in efficacy and precision as well as the crucial role of #CDMO partnerships. Click on the link below to read the full article: https://ald.bio/3QLffwz #AdvancingEveryday #DNA #mRNA #TeamAldevron

ICYMI Anytime a different therapeutics approach becomes widespread, analytics need to grow and improve to ensure safety and quality. #mRNA is no exception. As Nate Spangler discusses in his latest post, Analyze This, liquid chromatography-mass spectrometry offers a solution for better workflows. https://ald.bio/3QwkSPc

Aldevron was excited to participate in a study with InDevR, Inc. using a new chip-based technology for capping efficiency. We provided experimental samples that generated clean, fast, and quantitative results. InDevR used those results to create a case study which was recently published in Genetic Engineering & Biotechnology News. We are excited to share it with you! https://ald.bio/4i4n7W4